Inventor
MIRANDA LESLIE P
US25 patents
⚠️ This page may combine multiple inventors who share the name “MIRANDA LESLIE P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
20 patentsUS8008453B2Aug 30, 2011
Modified Fc molecules
AMGEN INC55 citations97
US7833979B2Nov 16, 2010
Toxin peptide therapeutic agents
AMGEN INC45 citations95
US7803769B2Sep 28, 2010
OSK1 peptide analogs and pharmaceutical compositions
AMGEN INC46 citations95
US7834164B2Nov 16, 2010
DNA encoding OSK1 toxin peptide analogs and vectors and cells for combinant expression
AMGEN INC9 citations92
US10905772B2Feb 2, 2021
Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR)
AMGEN INC6 citations82
US7820623B2Oct 26, 2010
Conjugated toxin peptide therapeutic agents
AMGEN INC10 citations82
US7825093B2Nov 2, 2010
Methods of using OSK1 peptide analogs
AMGEN INC4 citations73
US7910102B2Mar 22, 2011
Methods of using conjugated toxin peptide therapeutic agents
AMGEN INC4 citations72
US8043829B2Oct 25, 2011
DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expression
AMGEN INC6 citations71
US11807693B2Nov 7, 2023
Apelin polypeptides
AMGEN INC0 citations62
US11266744B2Mar 8, 2022
Modified Fc molecules
AMGEN INC0 citations62
US10941182B2Mar 9, 2021
Apelin polypeptides
AMGEN INC0 citations61
US12214051B2Feb 4, 2025
Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR)
AMGEN INC0 citations59
US11732266B2Aug 22, 2023
RNAi constructs for inhibiting ASGR1 expression and methods of use thereof
AMGEN INC0 citations57
US11643440B2May 9, 2023
Peptide PAC1 antagonists
AMGEN INC0 citations55
US10188740B2Jan 29, 2019
Modified Fc molecules
AMGEN INC0 citations51
US9796766B2Oct 24, 2017
Potent and selective inhibitors of NAV1.3 and NAV1.7
AMGEN INC0 citations48
US10870856B2Dec 22, 2020
RNAi constructs for inhibiting ASGR1 expression and methods of use thereof
AMGEN INC0 citations47
US9636418B2May 2, 2017
Potent and selective inhibitors of NAV1.7
AMGEN INC0 citations39
US10344060B2Jul 9, 2019
Potent and selective inhibitors of Nav1.7
AMGEN INC0 citations38